Advertisement
Advertisement
U.S. markets open in 2 hours
Advertisement
Advertisement
Advertisement
Advertisement

MediPharm Labs Corp. (MEDIF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0619+0.0009 (+1.56%)
At close: 03:36PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0610
Open0.0690
BidN/A x N/A
AskN/A x N/A
Day's Range0.0590 - 0.0690
52 Week Range0.0400 - 0.1730
Volume191,872
Avg. Volume122,439
Market Cap17.816M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-0.1420
Earnings DateMar 27, 2023 - Mar 31, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MEDIF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MEDIPHARM LABS CORP
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 22 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Rating
    Fair Value
    Economic Moat
    3 months agoMorningstar
View more
  • CNW Group

    IIROC Trade Resumption - LABS

    Trading resumes in:

  • CNW Group

    MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

    MediPharm Labs Corp. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") and VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO") today announced that MediPharm and VIVO have entered into a definitive arrangement agreement (the "Arrangement Agreement") whereby MediPharm has agreed to acquire VIVO in an all-equity business combination transaction (the "Transaction"). The Transaction is expected to combine two highly complementary businesses, creating a unique a

  • CNW Group

    IIROC Trading Halt - LABS

    The following issues have been halted by IIROC:

Advertisement
Advertisement